Search results
Mar 8, 2024 · Today, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults...
Apr 2, 2024 · In 2023, a clinical trial called Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) showed that Wegovy can significantly reduce the risk of major heart events—this time in people with extra weight and a cardiovascular condition who don’t have diabetes. Now, the FDA has expanded Wegovy’s approval ...
Mar 13, 2024 · The Food and Drug Administration (FDA) approved Novo Nordisk’s popular weight loss drug Wegovy for a new indication, extending its use to the prevention of heart attacks, stroke, and other cardiovascular problems in adults with heart disease and who have overweight or obesity.
Mar 13, 2024 · Injectable Wegovy (semaglutide) is now approved to reduce the risk of death due to heart attack, stroke, and death from cardiovascular disease. This new use is intended for people who are...
Nov 11, 2023 · In patients with preexisting cardiovascular disease and overweight or obesity but without diabetes, weekly subcutaneous semaglutide at a dose of 2.4 mg was superior to placebo in reducing the...
Mar 8, 2024 · The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA...
Mar 8, 2024 · The blockbuster weight loss drug Wegovy is now approved to reduce heart disease risk, drugmaker Novo Nordisk said Friday. The Food and Drug Administration has updated the drug's label, saying...
Mar 13, 2024 · On March 8, the FDA approved the semaglutide medication Wegovy to help reduce the risk of cardiovascular death, heart attack, and stroke in adults with heart disease who have obesity or...
Mar 26, 2024 · The Food and Drug Administration’s recently approved the anti-obesity drug to reduce the risk of heart attack and stroke. Even if just 10% of eligible enrollees are prescribed Wegovy — an...
Aug 8, 2023 · The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke, or heart disease-related death by 20% in a major clinical trial in people with cardiovascular disease, the first...
